Bd board of directors approves embecta spinoff and declares distribution of embecta stock

Franklin lakes, n.j., feb. 1, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as embecta corp. ("embecta") and declared a pro rata distribution of all of the outstanding shares of embecta common stock to bd shareholders.
BDX Ratings Summary
BDX Quant Ranking